PharmaCyte Biotech Selects Dr. Manuel Hidalgo as Principal Investigator for Its Pancreatic Cancer Clinical Trial
October 24, 2016 09:00 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., Oct. 24, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Cannabinoid Research Shows Promise for Success
October 10, 2016 09:20 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., Oct. 10, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte’s CEO Discusses Development of its Pancreatic Cancer Therapy
September 15, 2016 09:15 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., Sept. 15, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Reports on Progress in Its Medical Cannabis Program
September 01, 2016 09:15 ET
|
PharmaCyte Biotech, Inc.
LAGUNA HILLS, Calif., Sept. 01, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
Dr. Mark L. Rabe Presents PharmaCyte Biotech’s Ongoing Research at Cannabis Cancer Forum
August 02, 2016 09:00 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Aug. 02, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Releases Shareholder Call Playback Information
July 29, 2016 09:00 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., July 29, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing therapies for cancer and diabetes...
PharmaCyte Biotech Shareholder Call Update
July 25, 2016 09:00 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., July 25, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing therapies for cancer and diabetes using its...
PharmaCyte Biotech Receives Patent Protection of the Melligen Cells to Treat Diabetes
July 14, 2016 09:00 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., July 14, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing therapies for cancer and diabetes using its...
PharmaCyte Biotech to Hold Shareholder Call
July 11, 2016 09:00 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., July 11, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte’s Research on Medical Uses of Cannabinoids Supported by Recent Scientific Article
July 05, 2016 09:39 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., July 05, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...